Impact of chronic hepatitis B and hepatitis C on adverse hepatic fibrosis in hepatocellular carcinoma related to betel quid chewing

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 2, 2014, Pages 637-642

  Jeng, Jen Eing ^a   Tsai, Meng Feng ^b   Tsai, Hey Ru ^c   Chuang, Lea Yea ^d   Lin, Zu Yau ^a   Hsieh, Min Yuh ^a   Chen, Shinn Chern ^a   Chuang, Wan Lung ^a   Wang, Liang Yen ^a   Yu, Ming Lung ^a   Dai, Chia Yen ^a   Tsai, Jung Fa ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b Department of Pediatrics Sinchu MaKay Memorial Hospital   (Taiwan)

^c TAINAN SIN LAU HOSPITAL   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Betel quid chewing; Chronic hepatitis B and C; HCC; Risk factor; Surrogate markers for hepatic fibrosis

Indexed keywords

ADULT; AGED; ARECA; ARTICLE; CANCER STAGING; CASE CONTROL STUDY; COMPARATIVE STUDY; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; ISOLATION AND PURIFICATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TUMOR; MALE; MASTICATION; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RISK FACTOR; SURVIVAL RATE; VIROLOGY;

ADULT; AGED; ARECA; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HEPACIVIRUS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MASTICATION; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RISK FACTORS; SURVIVAL RATE;

EID: 84894640893     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.2.637     Document Type: Article

References (40)

1. Angadi PV, Rao SS (2011). Areca nut in pathogenesis of oral submucous fibrosis:Revisited. Oral Maxillofac Surg, 15, 1-9.
2. Bhide SV, Shivapurkar NM, Gothoskar SV, Ranadive KJ (1979). Carcinogenicity of betel nut ingredients: Feeding mice with aqueous extract and the polyphenol fraction of betel nut. Br J Cancer, 40, 922-6.
3. Bouchard MJ, Navas-Martin S (2011). Hepatitis B and C virus hepatocarcinogenesis: Lessons learned and future challenges. Cancer Lett, 305, 123-43.
4. Bruce MG, Bruden D, McMahon BJ, et al (2008). Clinical significance of elevated alpha-fetoprotein in Alaskan native patients with chronic hepatitis C. J Viral Hepatitis, 15, 179-87.
5. Chang LY, Wan HC, Lai YL, et al (2009). Areca nut extracts increased expression of inflammatory cytokines, tumor necrosis factor-alpha, interleukin-1beta, interleukin-6 and interleukin-8, in peripheral blood mononuclear cells. J Periodontal Res, 44, 175-83.
6. Chen CH, Yang PM, Huang GT, et al (2007). Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants. J Formosa Med Assoc, 106, 148-55.
7. El-Serag HB (2012). Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology, 142, 1264-73.
8. Greene FL, Page DL, Fleming ID, et al (2002). American Joint Committee on Cancer Staging Manual. 6th edn. Spring., Philadelphia.
9. Gumusay O, Ozenirler S, Atak A, et al (2013). Diagnostic potential of serum direct markers and non-invasive fibrosis models in patients with chronic hepatitis B. Hepatol Res, 43, 228-37.
10. Gupta PC, Warnakulasuriya S (2002). Global epidemiology of areca nut usage. Addict Biol 7, 77-83.
11. Hamed MA, Ali SA (2013). Non-viral factors contributing to hepatocellular carcinoma. World J Hepatol, 5, 311-22.
12. Hsiao TJ, Liao HW, Hsieh PS, Wong RH (2007). Risk of betel quid chewing on the development of liver cirrhosis: a community-based case-control study. Ann Epidemiol, 17, 479-85.
13. International Agency for Research on Cancer (IARC) (2004). Betel-quid and areca-nut chewing and some areca-nut derived nitrosamines. IARC Monogr Eval Carcinog Risks Hum, 85, 1-334.
14. Jemal A, Bray D, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
15. Jeng JE, Tsai HR, Chuang LY, et al (2009). Independent and additive interactive effects among tumor necrosis factor-α polymorphisms, substance use habits, and chronic hepatitis B and hepatitis C virus infection on risk for hepatocellular carcinoma. Medicine, 88, 349-57.
16. Jeng JE, Tsai JF, Chuang LY, et al (2007). Tumor necrosis factor-α 308.2 polymorphism is associated with advanced hepatic fibrosis and higher risk for hepatocellular carcinoma. Neoplasia, 9, 987-92.
17. Kee KM, Lu SN (2011). Hospital-and community-based screenings for hepatocellular carcinoma in Taiwan. Oncology, 81 Suppl, 36-40.
18. Ko YC, Chiang TA, Chang SJ, Hsieh SF (1992). Prevalence of betel quid chewing habit in Taiwan and related sociodemographic factors. J Oral Pathol Med, 21, 261-4.
19. Kong X, Horiguchi N, Mori M, Gao B (2012). Cytokines and STATs in liver fibrosis. Front Physiol, 3, 69.
20. Lackner C, Struber G, Liegl B, et al (2005). Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C. Hepatology, 41, 1376-82.
21. Lee CH, Ko AM, Warnakulasuriya S, et al (2011). Intercountry prevalences and practices of betel-quid use in south, southeast and eastern Asia regions and associated oral preneoplastic disorders: an international collaborative study by Asian betel-quid consortium of south and east Asia. Int J Cancer, 129, 741-51.
22. Lin CF, Shiau TJ, Ko YC, Chen PH, Wang JD (2008). Prevalence and det erminants of biochemical dysfunction of the liver in Atayala aboriginal community of Taiwan: is betel nut chewing a risk factor? BMC Gastroenterol, 8, 13.
23. Lee CH, Ko AM, Warnakulasuriya S, et al (2011). Intercountry prevalences and factors of betel-quid use in south, southeast and eastern Asia regions and associated oral preneoplastic disorders: an international collaborative study by Asian betel-quid consortium of south and east Asia. Int J Cancer, 129, 1741-51.
24. Lin CW, Hsieh YS, Hsin CH, et al (2012). Effects of NFKB1 and NFKBIA gene polymorphisms on susceptibility to environmental factors and the clinicopathologic development of oral cancer. PLoS One, 7, e35078.
25. Lu HH, Kao SY, Liu TY, et al (2010). Areca nut extract induced oxidative stress and upregulated hypoxia inducing factor leading to autophagy in oral cancer cells. Autophagy, 6, 725-37.
26. Lu SN, Wang JH, Liu SL, et al (2006). Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma. Cancer, 107, 2212-22.
27. Luedde T, Schwabe RF (2011). NF-κB in the liver-linking injury, fibrosis and hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol, 8, 108-18.
28. Matsuzaki K, Murata M, Yoshida K, et al (2007). Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma. Hepatology, 46, 48-57.
29. Murata M, Matsuzaki K, Yoshida K, et al (2009). Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B. Hepatology, 49, 1203-17.
30. Ni WF, Tsai CH, Yang SF, Chang YC (2007). Elevated expression of NF-kappaB in oral submucous fibrosis-evidence for NF-kappaB induction by safrole in human buccal mucosal fibroblasts. Oral Oncol, 43, 557-62.
31. Nishikawa A, Prokopczyk B, Rivenson A, Zang E, Hoffmann D (1992). A study of betel quid Carcinogenesis. VIII. Carcinogenicity of 3-(methylnitrosamino) propionaldehyde in F344 rats. Carcinogenesis, 13, 369-72.
32. Rodriguez-Diaz JL, Rosas-Camargo V, Vega-Vegaz O, et al (2007). Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: A long-term follow-up study. Clin Oncol, 9, 197-203.
33. Sarma AB, Chakrabarti J, Chakrabarti A, et al (1992). Evaluation of pan masala for toxic effects on liver and other organs. Food Chem Toxicol, 30, 161-3.
34. Secretan B, Straif K, Baan R, et al (2009). A review of human carcinogens-Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol, 10, 1033-4.
35. Tsai JF, Chang WY, Jeng JE, et al (1993). Hepatitis C virus infection as a risk factor for nonalcoholic liver cirrhosis in Taiwan. J Med Virol, 41, 296-300.
36. Tsai JF, Chuang LY, Jeng JE, et al (2001). Betel quid chewing as a risk factor for hepatocellular carcinoma: a case-control study. Br J Cancer, 84, 709-13.
37. Tsai JF, Jeng JE, Chuang LY, et al (2003). Habitual betel quid chewing as a risk factor for cirrhosis: a case-control study. Medicine, 82, 365-72.
38. Tsai JF, Jeng JE, Chuang LY, et al (2004). Habitual betel quid chewing and risk for hepatocellular carcinoma complicating cirrhosis. Medicine, 83, 176-87.
39. Yan LB, Zhu X, Bai L, et al (2013). Impact of mild to moderate elevations of alanine aminotransferase on liver stiffness measurement in chronic hepatitis B patients during antiviral therapy. Hepatol Res, 43, 185-91.
40. Zhang SS, Li WH, Gao YJ, et al (2012). Betel-quid and oral submoucous fibrosis study in Hunan province, China. J Oral Pathol Med, 41, 748-54.